Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin As Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE β Stella
Phase 4 β Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
(32 sites) South Korea
Hallym University Sacred Heart Hospital, Anyang Busan Paik Hospital, Busan Pusan National University Hospital, Busan Chungbuk National University Hospital, Cheongju-si Hallym University Chuncheon Sacred Heart Hospital, Chuncheon Kangwon National University Hospital, Chuncheon Keimyung University Dongsan Medical Center, Daegu Yeungnam University Medical Center, Daegu Chungnam National University Hospital, Daejeon Hanyang University Guri Hospital, Guri-si Chonnam National University Hospital, Gwangju Chosun University Hospital, Gwangju Gachon University Gil Medical Center, Incheon Inha University Hospital, Incheon Jeju National University Hospital, Jeju City Jeonbuk National University Hospital, Jeonju Chungnam National University Sejong Hospital, Sejong Seoul National University Bundang Hospital, Seongnam Asan Medical Center, Seoul Chung-Ang University Hospital, Seoul Ewha Woman University Seoul Hospital, Seoul Ewha Womans University Mokdong Hospital, Seoul Hallym University Kangdong Sacred Heart Hospital, Seoul Hanyang University Seoul Hospital, Seoul Konkuk University Medical Center, Seoul Korea University Anam Hospital, Seoul Kyung Hee University Medical Center, Seoul Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul Seoul National University Hospital, Seoul Severance Hospital, Seoul Uijeongbu Eulji Medical Center, Uijeongbu-si Yongin Severance Hospital, YΕngin
Key details Sponsor
Seoul National University Hospital
Collaborators
Samjin Pharmaceutical Co., Ltd.
Enrollment target
~200 participants
Primary completion
March 2029
Last updated October 2024